C T Whitlow1, K M Sink2, J Divers3, S C Smith4, J Xu4, N D Palmer5, C E Hugenschmidt2, J D Williamson2, D W Bowden5, B I Freedman6, J A Maldjian7. 1. From the Department of Radiology, Section of Neuroradiology (C.T.W., J.A.M.) Advanced Neuroscience Imaging Research Laboratory (C.T.W., J.A.M.) Department of Biomedical Engineering (C.T.W., J.A.M.) cwhitlow@wakehealth.edu. 2. Department of Internal Medicine, Section on Gerontology and Geriatric Medicine (K.M.S., C.E.H., J.D.W.). 3. Division of Public Health Sciences, Department of Biostatistical Sciences (J.D.). 4. Department of Biochemistry (S.C.S., J.X., N.D.P., D.W.B.). 5. Department of Biochemistry (S.C.S., J.X., N.D.P., D.W.B.) Center for Diabetes Research, Center for Genomics and Personalized Medicine Research (N.D.P., D.W.B., B.I.F.). 6. Center for Diabetes Research, Center for Genomics and Personalized Medicine Research (N.D.P., D.W.B., B.I.F.) Department of Internal Medicine, Section on Nephrology (B.I.F.), Wake Forest School of Medicine, Winston-Salem, North Carolina. 7. From the Department of Radiology, Section of Neuroradiology (C.T.W., J.A.M.) Advanced Neuroscience Imaging Research Laboratory (C.T.W., J.A.M.) Department of Biomedical Engineering (C.T.W., J.A.M.).
Abstract
BACKGROUND AND PURPOSE: Rates of type 2 diabetes are higher among African Americans compared with individuals of European ancestry. The purpose of this investigation was to determine the relationship between MR imaging measures of brain structure (volume of GM, WM, WM lesions) and cognitive function in a population of African Americans with type 2 diabetes. These MR imaging measures of brain structure are affected by type 2 diabetes-associated macrovascular and microvascular disease and may be associated with performance on tasks of cognitive function in the understudied African American population. MATERIALS AND METHODS: African Americans with type 2 diabetes enrolled in the African American-Diabetes Heart Study MIND study (n = 263) were evaluated across a broad range of cognitive domains and imaged with brain MR imaging. Associations between cognitive parameters and MR imaging measures of whole-brain GM, WM, and WM lesion volumes were assessed by using adjusted multivariate models. RESULTS: Lower GM volume was associated with poorer performance on measures of general cognitive function, working memory, and executive function. Higher WM lesion volume was associated with poorer performance on a smaller subset of cognitive domains compared with GM volume but included aspects of working memory and executive function. There were no statistically significant associations with WM volume. CONCLUSIONS: Markers of cortical atrophy and WM lesion volume are associated with cognitive function in African Americans with type 2 diabetes. These associations are described in an African American cohort with disease control similar to that of individuals of European ancestry, rather than underserved African Americans with poor access to health care. Interventions to reduce cortical atrophy and WM disease may improve cognitive outcomes in this understudied population.
BACKGROUND AND PURPOSE: Rates of type 2 diabetes are higher among African Americans compared with individuals of European ancestry. The purpose of this investigation was to determine the relationship between MR imaging measures of brain structure (volume of GM, WM, WM lesions) and cognitive function in a population of African Americans with type 2 diabetes. These MR imaging measures of brain structure are affected by type 2 diabetes-associated macrovascular and microvascular disease and may be associated with performance on tasks of cognitive function in the understudied African American population. MATERIALS AND METHODS: African Americans with type 2 diabetes enrolled in the African American-Diabetes Heart Study MIND study (n = 263) were evaluated across a broad range of cognitive domains and imaged with brain MR imaging. Associations between cognitive parameters and MR imaging measures of whole-brain GM, WM, and WM lesion volumes were assessed by using adjusted multivariate models. RESULTS: Lower GM volume was associated with poorer performance on measures of general cognitive function, working memory, and executive function. Higher WM lesion volume was associated with poorer performance on a smaller subset of cognitive domains compared with GM volume but included aspects of working memory and executive function. There were no statistically significant associations with WM volume. CONCLUSIONS: Markers of cortical atrophy and WM lesion volume are associated with cognitive function in African Americans with type 2 diabetes. These associations are described in an African American cohort with disease control similar to that of individuals of European ancestry, rather than underserved African Americans with poor access to health care. Interventions to reduce cortical atrophy and WM disease may improve cognitive outcomes in this understudied population.
Authors: Jorge Jovicich; Silvester Czanner; Xiao Han; David Salat; Andre van der Kouwe; Brian Quinn; Jenni Pacheco; Marilyn Albert; Ronald Killiany; Deborah Blacker; Paul Maguire; Diana Rosas; Nikos Makris; Randy Gollub; Anders Dale; Bradford C Dickerson; Bruce Fischl Journal: Neuroimage Date: 2009-02-20 Impact factor: 6.556
Authors: Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels Journal: Diabetes Care Date: 2010-03-18 Impact factor: 19.112
Authors: Reinhold Schmidt; Lenore J Launer; Lars-Göran Nilsson; Andrzej Pajak; Susanna Sans; Klaus Berger; Monique M Breteler; Maria de Ridder; Carole Dufouil; Rebecca Fuhrer; Simona Giampaoli; Albert Hofman Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: Hugh C Hendrie; Mengjie Zheng; Kathleen A Lane; Roberta Ambuehl; Christianna Purnell; Shanshan Li; Frederick W Unverzagt; Michael D Murray; Ashok Balasubramanyam; Chris M Callahan; Sujuan Gao Journal: Alzheimers Dement Date: 2018-04-18 Impact factor: 21.566
Authors: Barry I Freedman; Kaycee M Sink; Christina E Hugenschmidt; Timothy M Hughes; Jeff D Williamson; Christopher T Whitlow; Nicholette D Palmer; Michael E Miller; Laura C Lovato; Jianzhao Xu; S Carrie Smith; Lenore J Launer; Joshua I Barzilay; Robert M Cohen; Mark D Sullivan; R Nick Bryan; Benjamin C Wagner; Donald W Bowden; Joseph A Maldjian; Jasmin Divers Journal: Am J Kidney Dis Date: 2017-06-23 Impact factor: 8.860
Authors: Debra A Fleischman; Konstantinos Arfanakis; Sue E Leurgans; Shengwei Zhang; Victoria N Poole; S Duke Han; Lei Yu; Melissa Lamar; Namhee Kim; David A Bennett; Lisa L Barnes Journal: Neurobiol Aging Date: 2021-11-20 Impact factor: 5.133
Authors: Ochuko L Erukainure; Olajumoke A Oyebode; Collins U Ibeji; Neil A Koorbanally; Md Shahidul Islam Journal: Metab Brain Dis Date: 2019-01-03 Impact factor: 3.584
Authors: Barry I Freedman; Crystal A Gadegbeku; R Nick Bryan; Nicholas M Pajewski; Jasmin Divers; Nicholette D Palmer; Pamela J Hicks; Lijun Ma; Michael V Rocco; S Carrie Smith; Jianzhao Xu; Christopher T Whitlow; Benjamin C Wagner; Carl D Langefeld; Amret T Hawfield; Jeffrey T Bates; Alan J Lerner; Dominic S Raj; Mohammad S Sadaghiani; Robert D Toto; Jackson T Wright; Donald W Bowden; Jeff D Williamson; Kaycee M Sink; Joseph A Maldjian Journal: Kidney Int Date: 2016-06-22 Impact factor: 10.612
Authors: Fang-Chi Hsu; Mingxia Yuan; Donald W Bowden; Jianzhao Xu; S Carrie Smith; Lynne E Wagenknecht; Carl D Langefeld; Jasmin Divers; Thomas C Register; J Jeffrey Carr; Jeff D Williamson; Kaycee M Sink; Joseph A Maldjian; Barry I Freedman Journal: J Diabetes Complications Date: 2016-08-19 Impact factor: 2.852
Authors: Timothy M Hughes; Kaycee M Sink; Jeff D Williamson; Christina E Hugenschmidt; Benjamin C Wagner; Christopher T Whitlow; Jianzhao Xu; S Carrie Smith; Lenore J Launer; Joshua I Barzilay; Faramarz Ismail-Beigi; R Nick Bryan; Fang-Chi Hsu; Donald W Bowden; Joseph A Maldjian; Jasmin Divers; Barry I Freedman Journal: J Diabetes Complications Date: 2018-05-29 Impact factor: 2.852
Authors: Gargi Mahapatra; S Carrie Smith; Timothy M Hughes; Benjamin Wagner; Joseph A Maldjian; Barry I Freedman; Anthony J A Molina Journal: Clin Sci (Lond) Date: 2018-12-05 Impact factor: 6.124